Taichunamide‐A Inhibits Stomach Cancer Growth Through AKT/MAPK Pathway Suppression and EGFR Inhibitor Synergy

Documenti analoghi

• Synergistic Anticancer Effects of Silibinin and Sulforaphane: Targeting Gastric Cancer via PI3K/AKT and ERK1/2 MAPK Pathway Inhibition and Molecular Docking Insights
  di: Yanfeng Liu, et al.
  Pubblicazione: (2025)
• MT1H Inhibited Colon Cancer Development via Interacting With DUSP1 and MAPK Signaling Pathway Inactivation
  di: Lijun Jiang, et al.
  Pubblicazione: (2025)
• SRSF3 Inhibits High Glucose and Palmitic Acid‐Induced Cardiomyocyte Apoptosis Through the PI3K/AKT and NF‐κB Pathways
  di: Peng Gao, et al.
  Pubblicazione: (2025)
• Puerarin Enhances the Sensitivity of Colorectal Cancer to 5‐Fluorouracil and Oxaliplatin by Inhibiting the PTEN/PI3K/AKT Signaling Pathway
  di: Xiaowei Wang, et al.
  Pubblicazione: (2025)
• Ononin Inhibits the Growth and Metastasis of Hepatocellular Carcinoma by Suppressing MMP‐2 and MMP‐9 via PI3K/AKT/mTOR Signaling
  di: Shasha Peng, et al.
  Pubblicazione: (2026)